Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Journal of Gastroenterology and Hepatology|March 23, 2007
Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patientsLi-Po Lee, Chia-Yen Dai, Wan-Long Chuang, et al.
Journal of Hepatology|December 26, 2009
Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in TaiwanChia-Yen Dai, Chi-Kung Ho, Jee-Fu Huang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 31, 2013
Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinomaJen-Eing Jeng, Meng-Feng Tsai, Hey-Ru Tsai, et al.
Medicine|November 14, 2009
Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinomaJen-Eing Jeng, Huey-Ru Tsai, Lee-Yea Chuang, et al.
Medicine|March 18, 2008
Heat shock protein A1B 1267 polymorphism is highly associated with risk and prognosis of hepatocellular carcinoma: a case-control studyJen-Eing Jeng, Jung-Fa Tsai, Lea-Yea Chuang, et al.
The Journal of Infectious Diseases|December 3, 2005
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infectionChia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapyMing-Lung Yu, Shi-Ming Lin, Chuan-Mo Lee, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 18, 2003
Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primersChia Yen Dai, Ming Lung Yu, Zu Yau Lin, et al.
Plos One|January 4, 2013
Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirinMing-Lung Yu, Chen-Hua Liu, Chung-Feng Huang, et al.
Medicine|October 8, 2003
Habitual betel quid chewing as a risk factor for cirrhosis: a case-control studyJung-Fa Tsai, Jen-Eing Jeng, Lee-Yea Chuang, et al.
Pageof 9